Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-18-021483

SVP and Chief Development Off. acquired 25,000 shares (grant or award)

  • SVP and Chief Development Off. gave up 2,557 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pavliv Leo SVP and Chief Development Off. 2018-03-23 Grant or award +25,000 $6.70 $167,500 132,861 D
Pavliv Leo SVP and Chief Development Off. 2018-03-23 Shares withheld for taxes −2,557 $6.70 $17,132 130,304 D
Loading xslF345X03/doc4.xml…